Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of DAIKENCHUTO (TU-100), a Gastrointestinal Nerve Modulator, on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Female Patients With Functional Constipation

NCT01139216 is registered in ClinicalTrials.gov with Tsumura USA as lead sponsor.

NCT NCT01139216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01139216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of DAIKENCHUTO (TU-100), a Gastrointestinal Nerve Modulator, on Rectal Compliance, Rectal Sensation and Small Bowel and Colonic Transit in Female Patients With Functional Constipation
Lead sponsor
Tsumura USA
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2010
Completion date
November 30, 2012
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colonic transit, functional constipation, gastric emptying, rectal compliance, rectal sensation, small bowel transit, whole gut transit